Defense Biotechnology Strategy Act
Summary
The Defense Biotechnology Strategy Act directs the Secretary of Defense to develop a strategy regarding the national security implications of emerging biotechnologies. This includes assessing biotechnology's role in defense and improving relationships within the industry, across agencies, and internationally. The strategy aims to enhance biomanufacturing capabilities, update military specifications, and explore advanced market commitments for biotechnology products.
Expected Effects
The Act will likely lead to increased investment in biotechnology research and development for defense applications. It may also result in the integration of biotechnology into military planning and operations. This could strengthen national security and create new opportunities for the biotechnology industry.
Potential Benefits
- Enhanced national security through the application of biotechnology.
- Potential for economic growth in the biotechnology sector.
- Improved coordination between government agencies and private industry.
- Advancements in biomanufacturing capabilities.
- Strengthened international partnerships in biotechnology research.
Potential Disadvantages
- Potential for increased military spending.
- Ethical concerns related to the use of biotechnology in defense.
- Risk of unintended consequences from rapidly advancing technologies.
- Possible regulatory challenges in the development and deployment of biotechnology.
- Uncertainty regarding the long-term impact of biotechnology on national security.
Constitutional Alignment
The Act aligns with the Constitution's provision for the common defense (Preamble). Congress has the power to raise and support armies (Article I, Section 8). The Act falls under this purview by seeking to enhance national security through technological advancements.
Impact Assessment: Things You Care About ⓘ
This action has been evaluated across 19 key areas that matter to you. Scores range from 1 (highly disadvantageous) to 5 (highly beneficial).